{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:38:49Z","timestamp":1794220729150,"version":"4.8.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11904-007-0020-y","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T16:32:20Z","timestamp":1187368340000},"page":"135-140","source":"Crossref","is-referenced-by-count":54,"title":["Teratogenicity risk of antiretroviral therapy in pregnancy"],"prefix":"10.1007","volume":"4","author":[{"given":"D.","family":"Heather Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,18]]},"reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","volume":"331","author":"E.M. Connor","year":"1994","unstructured":"Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173\u20131180.","journal-title":"N Engl J Med"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00126334-200204150-00009","volume":"29","author":"E.R. Cooper","year":"2002","unstructured":"Cooper ER, Charurat M, Mofenson L, et al.: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002, 29:484\u2013494.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"20_CR3","unstructured":"Department of Health and Human Services: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. October 10, 2006. http:\/\/aidsinfo.nih.gov\/contentfiles\/AdultandAdolescentGL.pdf . Accessed March 1, 2007."},{"key":"20_CR4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1067\/mob.2001.113871","volume":"184","author":"H. Minkoff","year":"2001","unstructured":"Minkoff H, Ahdieh L, Watts DH, et al.: The relationship of pregnancy to the use of highly active antiretroviral therapy. Am J Obstet Gynecol 2001, 184:1221\u20131227.","journal-title":"Am J Obstet Gynecol"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1542\/peds.113.S3.984","volume":"113","author":"R.L. Brent","year":"2004","unstructured":"Brent RL: Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Pediatrics 2004, 113:984\u2013995.","journal-title":"Pediatrics"},{"key":"20_CR6","unstructured":"FDA Reviewer Guidance: Integration of study results to assess concerns about human reproductive and developmental toxicities. October 2001. http:\/\/www.fda.gov\/OHRMS\/DOCKETS\/98fr\/992079gd.pdf . Accessed March 1, 2007."},{"key":"20_CR7","unstructured":"Public Health Service Task Force: Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States\u2014October 12, 2006. Safety and toxicity of individual antiretroviral agents in pregnancy. http:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGLSafetyTox_Sup.pdf . Accessed March 5, 2007."},{"key":"20_CR8","unstructured":"The Antiretroviral Pregnancy Registry: Interim report. 1\/1\/89\u20137\/31\/06; issued December 2006. http:\/\/www.apregistry.com\/forms\/apr_report_706.pdf . Accessed May 4, 2007."},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.280.17.1472-JFD80010-3-1","volume":"280","author":"S.L. Nightingale","year":"1998","unstructured":"Nightingale SL: From the Food and Drug Administration. JAMA 1998, 280:1472.","journal-title":"JAMA"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.ogx.0000253377.14647.80","volume":"62","author":"H.T. Tilson","year":"2007","unstructured":"Tilson HT, Doi PA, Covington DL, et al.: The Antiretrovirals in Pregnancy Registry: a fifteenth anniversary celebration. Obstet Gynecol Surv 2007, 62:137\u2013148.","journal-title":"Obstet Gynecol Surv"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pds.982","volume":"13","author":"D.L. Covington","year":"2004","unstructured":"Covington DL, Tilson H, Elder J, Doi P: Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry. Pharmacoepidemiol Drug Safety 2004, 13:537\u2013545.","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"20_CR12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00126334-200304010-00006","volume":"32","author":"European Collaborative Study","year":"2003","unstructured":"European Collaborative Study: Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003, 32:380\u2013387.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"20_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.qai.0000196667.24239.c2","volume":"42","author":"C.L. Townsend","year":"2006","unstructured":"Townsend CL, Tookey PA, Cortina-Borja M, Peckham CS: Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990\u20132003. J Acquir Immune Defic Syndr 2006, 42:91\u201394.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"20_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/QAI.0b013e31802e2229","volume":"44","author":"D.H. Watts","year":"2007","unstructured":"Watts DH, Li D, Handelsman E, et al.: Assessment of birth defects according to maternal therapy among infants in WITS. J Acquir Immune Defic Syndr 2007, 44:299\u2013305.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00126334-200007010-00009","volume":"24","author":"C.J. Newschaffer","year":"2000","unstructured":"Newschaffer CJ, Cocroft J, Anderson CE, et al.: Prenatal zidovudine use and congenital anomalies in a Medicaid population. J Acquir Immune Defic Syndr 2000, 24:249\u2013256.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/sti.77.6.441","volume":"77","author":"E.M. Jungmann","year":"2001","unstructured":"Jungmann EM, Mercey D, DeRuiter A, et al.: Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities? Sex Transm Inf 2001, 77:441\u2013443.","journal-title":"Sex Transm Inf"},{"key":"20_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-2115(00)00288-8","volume":"93","author":"M.P. Richardson","year":"2000","unstructured":"Richardson MP, Osrin D, Donaghy S, et al.: Spinal malformations in the fetuses of HIV infected women receiving combination antiretroviral therapy and cotrimoxazole. Eur J Obstetric Gynecol Reprod Biol 2000, 93:215\u2013217.","journal-title":"Eur J Obstetric Gynecol Reprod Biol"},{"key":"20_CR18","unstructured":"Public Health Service Task Force: Recommendations for use of antiretroviral, drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States October 12, 2006. http:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL.pdf . Accessed March 1, 2007."},{"key":"20_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-6405-3-11","volume":"3","author":"M.F. Chersich","year":"2006","unstructured":"Chersich MF, Urban MF, Venter FWD, et al.: Efavirenz use during pregnancy and for women of child-bearing potential. AIDS Research Ther 2006, 3:11\u201317.","journal-title":"AIDS Research Ther"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-007-0020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-007-0020-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-007-0020-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T12:53:19Z","timestamp":1708174399000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-007-0020-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11904-007-0020-y","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}